The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Cloud in Medical Devices: Sensor integrated prosthesis. Buy the report here.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, CT angiography analysis automation, interactive nutrition monitoring and management, and clinical trials management systems are disruptive technologies that are in the early stages of application and should be tracked closely. Sensor integrated prosthesis, remote health monitoring networks, and AR/VR medical image visualisation are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is the computer assisted surgeries, which is now well established in the industry.
Innovation S-curve for cloud in the medical devices industry
Sensor integrated prosthesis is a key innovation area in cloud
Sensors are used in prosthesis to monitor movement in amputees, usually in the lower limb. Sensor integrated prosthesis provides information on parameters such as prosthetic function, the pressure generated during movement across tissue, and comfort. Sensor integrated prosthesis has replaced the conventional method of prosthesis customisation involving manufacturing prosthesis as per the size and customising it again based on patient’s feedback.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of sensor integrated prosthesis.
Key players in sensor integrated prosthesis – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to sensor-integrated prosthesis
|Company||Total patents (2010 - 2022)||Premium intelligence on the world's largest companies|
|Johnson & Johnson||90||Unlock Company Profile|
|Implantica Patent||66||Unlock Company Profile|
|Milux Holding||57||Unlock Company Profile|
|Canary Medical||39||Unlock Company Profile|
|UroMems||27||Unlock Company Profile|
|Intellectual Ventures Management||26||Unlock Company Profile|
|W. L. Gore & Associates||25||Unlock Company Profile|
|GraftWorx||24||Unlock Company Profile|
|Abbott Laboratories||19||Unlock Company Profile|
|Foundry Innovation & Research 1||18||Unlock Company Profile|
|Fulfillium||17||Unlock Company Profile|
|Gearbox||11||Unlock Company Profile|
|Assistance Publique - Hopitaux de Paris||10||Unlock Company Profile|
|Endotronix||9||Unlock Company Profile|
|Vactronix Scientific||9||Unlock Company Profile|
|Vesiflo||8||Unlock Company Profile|
|Zimmer Biomet Holdings||8||Unlock Company Profile|
|Lape Medical Societe Par Actions Simplifiee||8||Unlock Company Profile|
|International Business Machines||7||Unlock Company Profile|
|Smith & Nephew||7||Unlock Company Profile|
|Truffle Capital||6||Unlock Company Profile|
|Strathspey Crown||6||Unlock Company Profile|
|Elenza||6||Unlock Company Profile|
|BoneTag||5||Unlock Company Profile|
|Siemens||5||Unlock Company Profile|
|Emerson Electric||5||Unlock Company Profile|
|Sensome||5||Unlock Company Profile|
Source: GlobalData Patent Analytics
Johnson & Johnson is one of the leading patent filers in the field of sensor integrated prosthesis. Some other key patent filers in the field include Implantica Patent and Milux.
In terms of application diversity, Endotronix leads the pack, followed by International Business Machines (IBM) and Milux. By means of geographic reach, Implantica Patent holds the top position, followed by BoneTag and Emerson Electric in second and third spots, respectively.
Advancements in technologies would allow data generated by sensor integrated prosthesis to be stored in the cloud, which can then be monitored in real-time by healthcare professionals, patients, and manufacturers. This would allow a better understanding of prosthesis requirements, thus reducing the burden on healthcare providers and manufacturers for repeat customisation along with enhancing patient care.
To further understand how Cloud is disrupting the medical devices industry, access GlobalData’s latest thematic research report on Cloud Computing in Medical Devices.